Leaders from Sanofi and its Genzyme and Sanofi Pasteur subsidiaries will be participating in provocative, sessions focused on pressing issues affecting the biopharmaceutical industry during this year’s BIO International Convention, including two Super Sessions, twelve Breakout Sessions and the Keynote Luncheons. In line with its commitment to furthering life science research to bring needed treatment options to patients worldwide, Sanofi has sponsored various aspects of the BIO Convention to promote scientific collaboration and innovation, including the Orphan Disease Forum and the Innovation in Vaccines track.
2012 BIO International Convention
Jun 18, 2012 - Jun 21, 2012
Press Kit Files
|BIOtech Now Show Daily - Putting Patients at the Heart of What We Do|
|BIOtech Now Show Daily - Time for TMED|
|Sanofi Executive Bios|
|Sanofi Fact Sheets|
|Sanofi in the Massachusetts Area|
|Sanofi Pasteur Partnering|
|This is Genzyme|
Information contained in the Online Press Kit is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Requests to copy, circulate or further distribute Online Press Kit documents or content (other than copying for the limited purpose of an individual user's reference) should be submitted to the contact person identified in the Online Press Kit.
Any other requests to copy, circulate or further distribute Online Press Kit documents or content should be made by calling the Business Wire Research Department at +1 800.227.0845.